- ►bmj.com [PDF] JB Jonas, I Akkoyun, I Kreissig, RF Degenring - British Medical Journal, 2005 - bjo.bmj.com Diffuse diabetic macular oedema treated by intravitreal ... JB Jonas, I
Akkoyun, I Kreissig, RF Degenring ..............................................
............................................................................ ... Cited by 55 - Related articles - All 8 versions
A ÖZKIRIS, C Evereklioglu, K Erkilic, N … - European journal of ophtalmology, 2004 - cat.inist.fr PURPOSE. To evaluate the effectiveness of intravitreal triamcinolone injection
on the course of diabetic macular edema. METHODS. Forty-eight eyes of 48
diabetic patients were treated with 8 mg of intravitreal triamcinolone ... Cited by 58 - Related articles - All 4 versions
… , CKMCM MRCOphth, EWHT MB, KKW Li, … - Clinical & experimental ophthalmology - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 39 - Related articles - BL Direct - All 4 versions
JB Jonas, B Harder, BA Kamppeter - American journal of ophthalmology, 2004 - Elsevier In the study group, visual acuity increased significantly (P ≤ .001) by 3.0 ±
2.6 Snellen lines to a peak at two to six months after the injection, and
decreased significantly (P = .001) towards the end of follow up. At the end ... Cited by 26 - Related articles - All 13 versions
JB Jonas, R Degenring, I Kreissig, I Akkoyun - American journal of ophthalmology, 2004 - Elsevier Forty-six patients (47 eyes) received at least two intravitreal injections of
approximately 20 to 25 mg triamcinolone acetonide for treatment of diabetic
macular edema (n = 6 eyes), exudative age-related macular degeneration (n = ... Cited by 48 - Related articles - All 11 versions
JB Jonas, P Martus, RF Degenring, I Kreissig, … - Archives of Ophthalmology, 2005 - Am Med Assoc Results In a multiple linear regression analysis, maximum gain in best-corrected
visual acuity after the intravitreal injection of triamcinolone was
significantly (P < .001) and negatively correlated with an increased degree ... Cited by 28 - Related articles - BL Direct - All 4 versions
DSC Lam, CKM Chan, S Mohamed, TYY Lai, … - Eye, 2004 - nature.com In total, 17 eyes completed 6 months of follow-up. In all, 58.8% showed
improvement in BCVA of 2 lines, with statistically significant improvement in
mean Snellen BCVA of 2.4 lines at 6 months. The peak BCVA was achieved at 4 ... Cited by 18 - Related articles - All 5 versions
SJ BAKRI, PM BEER - Canadian journal of ophthalmology, 2004 - cat.inist.fr Contexte: Un nombre important d'yeux ayant un oedème maculaire diabétique
demeurent réfractaires au traitement malgré les nombreuses tentatives de
photocoagulation. L'on a rapporté que l'acétonide de triamcinolone, ... Cited by 20 - Related articles - All 2 versions
JB Jonas, RF Degenring, BA Kamppeter, I … - American journal of ophthalmology, 2004 - Elsevier To evaluate the duration of the effect of intravitreal triamcinolone acetonide
on visual acuity in patients with diffuse diabetic macular edema. ... Subjects
were 31 patients (38 eyes) with diffuse diabetic macular edema who received ... Cited by 106 - Related articles - All 16 versions
